ClearPoint Neuro (CLPT) Competitors $10.00 -0.40 (-3.85%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$10.07 +0.07 (+0.75%) As of 08/1/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLPT vs. ESTA, BLFS, TNDM, PLSE, MDXG, INMD, KMTS, SIBN, IRMD, and EMBCShould you be buying ClearPoint Neuro stock or one of its competitors? The main competitors of ClearPoint Neuro include Establishment Labs (ESTA), BioLife Solutions (BLFS), Tandem Diabetes Care (TNDM), Pulse Biosciences (PLSE), MiMedx Group (MDXG), InMode (INMD), Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. ClearPoint Neuro vs. Its Competitors Establishment Labs BioLife Solutions Tandem Diabetes Care Pulse Biosciences MiMedx Group InMode Kestra Medical Technologies SiBone iRadimed Embecta ClearPoint Neuro (NASDAQ:CLPT) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment. Do institutionals & insiders believe in CLPT or ESTA? 30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 7.0% of ClearPoint Neuro shares are owned by insiders. Comparatively, 11.1% of Establishment Labs shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has higher valuation and earnings, CLPT or ESTA? ClearPoint Neuro has higher earnings, but lower revenue than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than ClearPoint Neuro, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearPoint Neuro$31.39M8.92-$18.91M-$0.76-13.16Establishment Labs$166.02M7.20-$84.60M-$3.10-13.34 Does the media prefer CLPT or ESTA? In the previous week, Establishment Labs had 1 more articles in the media than ClearPoint Neuro. MarketBeat recorded 3 mentions for Establishment Labs and 2 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 0.74 beat Establishment Labs' score of 0.55 indicating that ClearPoint Neuro is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, CLPT or ESTA? ClearPoint Neuro has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Is CLPT or ESTA more profitable? Establishment Labs has a net margin of -52.34% compared to ClearPoint Neuro's net margin of -64.51%. ClearPoint Neuro's return on equity of -78.09% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets ClearPoint Neuro-64.51% -78.09% -51.33% Establishment Labs -52.34%-196.25%-26.64% Do analysts prefer CLPT or ESTA? ClearPoint Neuro currently has a consensus price target of $19.67, indicating a potential upside of 96.67%. Establishment Labs has a consensus price target of $54.83, indicating a potential upside of 32.64%. Given ClearPoint Neuro's stronger consensus rating and higher probable upside, research analysts plainly believe ClearPoint Neuro is more favorable than Establishment Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83 SummaryClearPoint Neuro beats Establishment Labs on 9 of the 16 factors compared between the two stocks. Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLPT vs. The Competition Export to ExcelMetricClearPoint NeuroMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$291.09M$6.77B$5.48B$9.51BDividend YieldN/A1.32%4.73%4.09%P/E Ratio-13.1620.9428.6723.80Price / Sales8.9254.14373.9066.58Price / CashN/A20.5035.4557.96Price / Book10.874.468.275.55Net Income-$18.91M$174.54M$3.24B$259.03M7 Day Performance-10.95%-5.27%-3.69%-4.59%1 Month Performance-11.43%-3.94%4.33%4.46%1 Year Performance43.68%8.26%25.95%18.03% ClearPoint Neuro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLPTClearPoint Neuro2.73 of 5 stars$10.00-3.8%$19.67+96.7%+47.1%$291.09M$31.39M-13.16110Positive NewsAnalyst ForecastGap DownESTAEstablishment Labs1.7034 of 5 stars$42.48+0.2%$54.83+29.1%-2.8%$1.23B$166.02M-13.701,018Upcoming EarningsBLFSBioLife Solutions2.7997 of 5 stars$22.23-1.6%$31.00+39.5%-10.9%$1.08B$82.25M-76.65440Upcoming EarningsGap DownTNDMTandem Diabetes Care3.5041 of 5 stars$16.84+6.0%$32.71+94.3%-56.3%$1.06B$940.20M-6.062,650Positive NewsUpcoming EarningsPLSEPulse Biosciences3.9173 of 5 stars$15.21+1.9%$22.00+44.6%-2.3%$1.00B$700K0.00140News CoverageMDXGMiMedx Group3.1093 of 5 stars$6.79+0.3%$11.50+69.4%+7.2%$999.94M$348.88M25.15870News CoveragePositive NewsEarnings ReportAnalyst ForecastAnalyst RevisionINMDInMode3.1262 of 5 stars$14.54-1.2%$18.54+27.5%-17.1%$930.44M$394.82M6.24480News CoverageEarnings ReportAnalyst ForecastKMTSKestra Medical Technologies0.9976 of 5 stars$16.50-0.3%$27.33+65.7%N/A$849.82M$59.81M0.00300Positive NewsSIBNSiBone3.7055 of 5 stars$17.60+2.0%$22.50+27.8%+17.2%$735.10M$167.18M-27.50350Upcoming EarningsIRMDiRadimed4.1955 of 5 stars$57.11+1.4%$72.00+26.1%+43.4%$716.11M$73.24M36.85110News CoverageEarnings ReportDividend AnnouncementGap UpEMBCEmbecta4.6458 of 5 stars$11.33-3.4%$19.00+67.7%-35.3%$685.53M$1.12B12.592,100News CoverageUpcoming Earnings Related Companies and Tools Related Companies Establishment Labs Competitors BioLife Solutions Competitors Tandem Diabetes Care Competitors Pulse Biosciences Competitors MiMedx Group Competitors InMode Competitors Kestra Medical Technologies Competitors SiBone Competitors iRadimed Competitors Embecta Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLPT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLPT Stock Alerts